May 22, 2026
TB-500 Complete Research Guide: Thymosin Beta-4 Tissue Repair and Recovery
TB-500 and Thymosin Beta-4 preclinical research: ILK-Akt signaling, anti-fibrotic mechanisms, and tissue repair findings across animal models.
RESEARCH NOTES
Research.
Read →
May 22, 2026
Longevity Stack: Epithalon GHK-Cu NAD+ Anti-Aging Protocol Research
Longevity Stack: Epithalon, GHK-Cu & NAD+ — preclinical mechanisms, data tables, and stack convergence points reviewed.
May 22, 2026
GLP-1 Pathway Stack: GLP-1 and Retatrutide Metabolic Research Protocol
GLP-1 and Retatrutide preclinical research: triple-receptor metabolic mechanisms, body composition data, and protocol context for the GLP-1 Pathway Stack.
May 14, 2026
BPC-157 vs TB-500: Tissue Repair Mechanism Comparison
Explore the BPC-157 vs TB-500 comparison: mechanisms, molecular targets, and preclinical research findings in tendon, muscle, cardiac, and CNS repair models.
May 14, 2026
Ipamorelin vs GHRP-2 vs Hexarelin: Research Comparison
Explore how Ipamorelin, GHRP-2, and Hexarelin compare in preclinical GHRP research: receptor selectivity, GH pulse, cortisol effects, and research applications.
May 14, 2026
mTOR Signaling Peptide Research: A Mechanistic Guide
Explore mTOR signaling peptide research: mTORC1 vs mTORC2, GHRPs, AMPK counter-regulation, and preclinical findings on protein synthesis and longevity.
May 14, 2026
GH IGF-1 Axis Research: GHRH, GHRP Peptide Mechanisms
Explore GH IGF-1 axis research: GHRH and GHRP receptor mechanisms, pulsatile GH release, IGF-1 downstream effects, and somatostatin regulation in animal models.
May 14, 2026
Thymosin Alpha-1 Selank Stack: Preclinical Research
Explore preclinical research on the Thymosin Alpha-1 Selank stack — immune modulation, GABAergic signalling, and stress-axis findings in animal models.
May 14, 2026
Ipamorelin CJC-1295 Stack: GH Secretagogue Research
Explore preclinical research on the Ipamorelin CJC-1295 stack: dual-mechanism GH amplification, IGF-1 elevation, selectivity data, and rodent model findings.
May 14, 2026
Tirzepatide GLP-1 GIP: Dual Agonist Preclinical Research
Explore preclinical Tirzepatide GLP-1 GIP dual agonist research: receptor mechanisms, SURPASS data context, metabolic effects vs semaglutide and retatrutide.